Skip to main content
BrainCited

Resveratrol für Cerebrovascular Health

C

Research suggests resveratrol may improve cerebral blood flow through nitric oxide-mediated vasodilation and activation of neuroprotective SIRT1 pathways. Bioavailability remains a key challenge.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dresveratrol\u0026condition\u003Dcerebrovascular\u002Dhealth'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

Fazit

Research suggests resveratrol may improve cerebral blood flow through nitric oxide-mediated vasodilation and activation of neuroprotective SIRT1 pathways. Bioavailability remains a key challenge.

Key Study Findings

Systematic Review
Investigating the impact of resveratrol and quercetin on glymphatic function, blood-brain barrier, and neuroglial health: …
Dose: None vs.: None Outcome: effects on glymphatic function, BBB permeability, neuroglial health Wirkung: None None

Population: experimental models and clinical trials on Alzheimer's, Parkinson's, and multiple sclerosis

Review
Dietary Antioxidants, Polyphenols, and Vascular Health: Insights From Ultrasound Measurement of Carotid Intima-Media Thickness and …
Dose: None vs.: None Outcome: None Wirkung: None None

Population: older adults and individuals with neurodegenerative disorders

In Vitro
Resveratrol attenuates the CoCl2-induced hypoxia damage by regulation of lysine β-hydroxybutyrylation in PC12 cells.
Dose: None vs.: CoCl2-induced hypoxia without resveratrol Outcome: Cell viability and Kbhb modulation under hypoxia Wirkung: None None

Population: PC12 rat pheochromocytoma cells

Controlled Clinical Trial
[Verification of resveratrol ameliorating vascular endothelial damage in sepsis-associated encephalopathy through HIF-1α pathway based on …
Dose: 40 or 60 mg/kg vs.: CLP group (0.9% NaCl) Outcome: Cerebrovascular endothelial barrier function Wirkung: None None

Population: CLP-induced sepsis-associated encephalopathy mice

Systematic Review
The Effects of Resveratrol on Menopausal Cardio-metabolic Changes: A Systematic Review.
Dose: None vs.: Placebo or no treatment Outcome: Cardiometabolic changes in menopausal women Wirkung: None None

Population: Menopausal women

Key Statistics

8

Studien

600

Teilnehmer

Positive

C

Bewertung

Referenced Papers

International journal of … 2021 50 Zitierungen
Oxidative medicine and … 2017 87 Zitierungen
Integrative medicine research 2014 51 Zitierungen
Annals of the … 2013 31 Zitierungen
Ageing research reviews 2010 228 Zitierungen
Genes & nutrition 2010 64 Zitierungen
Journal of cardiovascular … 2009 297 Zitierungen

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Übliche Dosierungen

general:
150-500 mg/day trans-resveratrol
cognitivesupport:
200-500 mg/day

Obergrenze: 5,000 mg/day (highest dose in clinical trials)

In der Forschung untersuchte Dosierungen

Dosierung Dauer Wirkung N
None -- Positive --
None -- Positive --
None -- Positive --
None -- Mixed --
40 or 60 mg/kg -- Positive --
None -- Positive --
None -- Mixed --
250 mg single dose -- Positive 16

Beste Einnahmezeit: With meals containing fat; morning preferred

Safety & Side Effects

Gemeldete Nebenwirkungen

  • Gastrointestinal discomfort
  • Headache
  • Diarrhea at high doses

Bekannte Wechselwirkungen

  • Anticoagulants (may increase bleeding risk)
  • CYP450 substrates (affects drug metabolism)
  • Estrogen-sensitive conditions (weak estrogenic activity)

Tolerierbare Höchstaufnahmemenge: 5,000 mg/day (highest dose in clinical trials)

Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.

Frequently Asked Questions

Does Resveratrol help with Cerebrovascular Health?
Based on 8 studies with 600 participants, there is limited but promising evidence that Resveratrol may support Cerebrovascular Health management. Our evidence grade is C (Some Evidence).
How much Resveratrol should I take for Cerebrovascular Health?
Studies have used various dosages. A commonly studied range is 150-500 mg/day trans-resveratrol. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Resveratrol?
Reported side effects may include Gastrointestinal discomfort, Headache, Diarrhea at high doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Resveratrol and Cerebrovascular Health?
We rate the evidence as Grade C (Some Evidence). This rating is based on 8 peer-reviewed studies with 600 total participants. The overall direction of effect is positive.

Related Evidence

Andere Inhaltsstoffe für Cerebrovascular Health

FDA-Haftungsausschluss: Diese Aussagen wurden nicht von der Food and Drug Administration bewertet. Die Produkte und Informationen auf dieser Website sind nicht dazu bestimmt, Krankheiten zu diagnostizieren, zu behandeln, zu heilen oder zu verhindern. Die dargestellten Evidenzbewertungen basieren auf unserer Analyse veröffentlichter begutachteter Forschung und stellen keine medizinische Beratung dar. Konsultieren Sie immer Ihren Arzt, bevor Sie mit der Einnahme von Nahrungsergänzungsmitteln beginnen.